Resource utilization associated with the management of potential interactions between direct-acting antivirals for chronic hepatitis C treatment and cardiovascular and central nervous system drugs
Evaluation of the additional actions and resource utilization required for the management of potential drug-drug interactions in HCV patients showing cardiovascular and central nervous system comorbidities, treated with sofosbuvir/velpatasvir compared to glecaprevir/ pibrentasvir in routine clinical practice in Spain.
Healthcare resource use and associated costs in a cohort of hospitalized COVID-19 patients in Spain: A retrospective analysis from the first to the third pandemic wave. EPICOV study
We conducted a retrospective observational study to describe healthcare resource use and costs per hospitalized coronavirus disease-2019 (COVID-19) patient during the three main outbreak waves.
Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain
A discrete choice experiment to explore societal preferences (of parents and pediatricians) regarding the attributes of a MenB vaccine in Spain.
Preferencias sociales en la vacunación frente a la enfermedad meningocócica invasiva causada por neisseria meningitidis del serogrupo b en España
Parents’ and paediatricians’ preferences for the characteristics of the vaccines against MenB.
Uso de recursos y costes asociados a las comorbilidades cardiovascular, renal, ósea y neuropsiquiátrica en pacientes con infección por VIH en España
Economic impact based on a scenario analysis to estimate the cost of cardiovascular, renal, bone and neuropsychiatric comorbidities in people living with human immunodeficiency virus in a current scenario versus alternative scenarios that simulate an increase in comorbidities due to toxicity that could be associated with certain treatments, over a 10-year time horizon and from […]
Uso de recursos durante la hospitalización y un año tras el alta en pacientes críticos con COVID-19 supervivientes a la primera ola de la pandemia. Estudio NUTRICOVID
The study describes the use of resources associated with COVID-19 in intensive care unit patients who survived the first wave of the pandemic during their hospitalisation and one year after discharge.
Long-term nutritional, functional status and health-related quality of life of critically ill COVID-19 survivors: one-year follow-up of NUTRICOVID study
This work aimed to show nutritional, functional and health-related quality of life outcomes in critically ill patients surviving COVID-19 one year after hospital discharge. A 12 months post-discharge ICU COVID-19 survivors showed a significant improvement in their nutritional and funcional status, as well as their HRQoL.
One-year post-discharge healthcare resources utilisation of critically ill COVID-19 survivors from NUTRICOVID study
This work aimed to describe the HRU of COVID-19 ICU survivors from the NUTRICOVID cohort for one year after discharge.
Análisis de los costes asociados al seguimiento de pacientes con VIH que discontinúan el tratamiento antirretroviral por falta de eficacia o toxicidad inaceptable en España
Analysis of the costs associated with the follow-up of HIV patients discontinuing antiretroviral treatment due to lack of effectiveness or unacceptable toxicity in Spain compared to the costs involved in the routine follow-up of patients on antiretroviral treatment.
Impact of COVID-19 in nutritional and functional status of survivors admitted in intensive care units during the first outbreak. Preliminary results of the NUTRICOVID study
